235 related articles for article (PubMed ID: 37016382)
1. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo-YAP1 pathway.
Liu D; Liu Y; Zhu W; Lu Y; Zhu J; Ma X; Xing Y; Yuan M; Ning B; Wang Y; Jia Y
BMC Med; 2023 Apr; 21(1):134. PubMed ID: 37016382
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of microRNA-204 by Helicobacter pylori augments the NF-κB signaling pathway in gastric cancer development and progression.
Chen P; Guo H; Wu X; Li J; Duan X; Ba Q; Wang H
Carcinogenesis; 2020 Jun; 41(4):430-441. PubMed ID: 31873718
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide-binding protein subunit beta-4 promotes gastric cancer progression via activating Erk1/2.
Gao J; Pan H; Zhu Z; Yu T; Huang B; Zhou Y
Acta Biochim Biophys Sin (Shanghai); 2020 Sep; 52(9):975-987. PubMed ID: 32747927
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism.
Zhao R; Liu Z; Xu W; Song L; Ren H; Ou Y; Liu Y; Wang S
Cancer Med; 2020 Apr; 9(7):2551-2563. PubMed ID: 32017451
[TBL] [Abstract][Full Text] [Related]
5. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by
Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ
World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343
[TBL] [Abstract][Full Text] [Related]
6. H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling.
Chen B; Liu X; Yu P; Xie F; Kwan JSH; Chan WN; Fang C; Zhang J; Cheung AHK; Chow C; Leung GWM; Leung KT; Shi S; Zhang B; Wang S; Xu D; Fu K; Wong CC; Wu WKK; Chan MWY; Tang PMK; Tsang CM; Lo KW; Tse GMK; Yu J; To KF; Kang W
Clin Transl Med; 2023 Nov; 13(11):e1481. PubMed ID: 37983931
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-induced RASAL2 Through Activation of Nuclear Factor-κB Promotes Gastric Tumorigenesis via β-catenin Signaling Axis.
Cao L; Zhu S; Lu H; Soutto M; Bhat N; Chen Z; Peng D; Lin J; Lu J; Li P; Zheng C; Huang C; El-Rifai W
Gastroenterology; 2022 May; 162(6):1716-1731.e17. PubMed ID: 35134322
[TBL] [Abstract][Full Text] [Related]
8. The Gamma-glutamyltransferase gene of Helicobacter pylori can promote gastric carcinogenesis by activating Wnt signal pathway through up-regulating TET1.
Meng L; Shi H; Wang Z; Fan M; Pang S; Lin R
Life Sci; 2021 Feb; 267():118921. PubMed ID: 33358913
[TBL] [Abstract][Full Text] [Related]
9.
Zhu S; Soutto M; Chen Z; Peng D; Romero-Gallo J; Krishna US; Belkhiri A; Washington MK; Peek R; El-Rifai W
Gut; 2017 May; 66(5):761-762. PubMed ID: 27590997
[TBL] [Abstract][Full Text] [Related]
10. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-κB-mediated expression of CEACAM1-3S in human gastric cancer.
Lin S; Zhang Y; Hu Y; Yang B; Cui J; Huang J; Wang JM; Xing R; Lu Y
Gastric Cancer; 2019 Sep; 22(5):941-954. PubMed ID: 30778796
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathway.
Hu Y; Liu JP; Li XY; Cai Y; He C; Li NS; Xie C; Xiong ZJ; Ge ZM; Lu NH; Zhu Y
Cancer Lett; 2019 May; 450():144-154. PubMed ID: 30849478
[TBL] [Abstract][Full Text] [Related]
13. Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression.
Shang W; Liang X; Li S; Li T; Zheng L; Shao W; Wang Y; Liu F; Ma L; Jia J
EBioMedicine; 2020 Mar; 53():102672. PubMed ID: 32114387
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
15. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
16. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
17. Involvement of APRIL in Helicobacter pylori-related gastric cancer.
Zhang Q; Ni Y; Zhi X; Wang J; Li Z; Tang J; Wang L; Wang W; Xu Z
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1685-1697. PubMed ID: 33738544
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1β activation of nitric oxide production in gastric cancer cells.
Huang FY; Chan AO; Rashid A; Wong DK; Cho CH; Yuen MF
Cancer; 2012 Oct; 118(20):4969-80. PubMed ID: 22415887
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.
Cheng AS; Li MS; Kang W; Cheng VY; Chou JL; Lau SS; Go MY; Lee CC; Ling TK; Ng EK; Yu J; Huang TH; To KF; Chan MW; Sung JJ; Chan FK
Gastroenterology; 2013 Jan; 144(1):122-133.e9. PubMed ID: 23058321
[TBL] [Abstract][Full Text] [Related]
20. Fas-associated factor 1 inhibits tumor growth by suppressing Helicobacter pylori-induced activation of NF-κB signaling in human gastric carcinoma.
Liu AQ; Xie Z; Chen XN; Feng J; Chen JW; Qin FJ; Ge LY
Oncotarget; 2017 Jan; 8(5):7999-8009. PubMed ID: 28030825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
